Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles (NDC: 68788-7388-6), c) 90 count bottles (NDC: 68788-7388-9), d) 100 count bottles (NDC: 68788-7388-1)
Published January 29, 2020 · Recall initiated: January 7, 2020
Summary
FDA records drug Class II recall D-0796-2020, published January 29, 2020 and initiated January 7, 2020. Recalling firm: Preferred Pharmaceuticals, Inc; Status: Terminated; Reported quantity: 221,710 tablets; Lot: Lot #: All lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Presence of NDMA impurity detected in product.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Preferred Pharmaceuticals, Inc
- Distributor
- Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and SC
- Lot
- Lot #: All lots within expiry
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPreferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1),January 29, 2020
- FDARanitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDCJanuary 29, 2020
- FDARanitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDCJanuary 29, 2020
- FDARanitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDCDecember 18, 2019
- FDANeomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 gJuly 31, 2019
- FDARobafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextromethorphan HBr, USP 10mg,/Guaifenesin,June 26, 2019
Questions about this recall
Was Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles (NDC: 68788-7388-6), c) 90 count bottles (NDC: 68788-7388-9), d) 100 count bottles (NDC: 68788-7388-1) recalled?
Yes. FDA published recall D-0796-2020 on January 29, 2020. Reported hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone